Literature DB >> 2835222

Factors controlling induction of commitment of murine erythroleukemia (TSA8) cells to CFU-E (colony forming unit-erythroid).

T Noguchi1, H Fukumoto, Y Mishina, M Obinata.   

Abstract

On addition of DMSO, the MEL cell line TSA8 becomes committed into erythroid progenitor cells (CFU-E) which can form differentiated colonies in the presence of erythropoietin. To understand the mechanism of cellular commitment, the number and the affinity of the receptors for erythropoietin were estimated. The affinity of the receptors did not change before or after induction. The number of receptors changed depending on the growth phase, but was not dependent on the addition of the inducer. Thus, the presence of the receptors for erythropoietin may be required, but are not essential for responsiveness to erythropoietin. Further examination of the optimum conditions for commitment suggests that the concomitant actions of induced factor(s) with the receptors may control commitment of TSA8 cells to CFU-E.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2835222     DOI: 10.1242/dev.101.1.169

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  3 in total

1.  Structure and transcription of the mouse erythropoietin receptor gene.

Authors:  H Youssoufian; L I Zon; S H Orkin; A D D'Andrea; H F Lodish
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

2.  Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide.

Authors:  V C Broudy; N Lin; J Egrie; C de Haën; T Weiss; T Papayannopoulou; J W Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Differentiation of erythroid progenitor (CFU-E) cells from mouse fetal liver cells and murine erythroleukemia (TSA8) cells without proliferation.

Authors:  T Noguchi; H Fukumoto; Y Mishina; M Obinata
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.